A Comparative Study Between ABP 501 and Humira ® in Participants With Moderate to Severe Plaque Psoriasis
Condition: Plaque Psoriasis Interventions: Drug: Adalimumab; Drug: ABP 501 Sponsor: Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials